CYPH - Cytoclonal Pharmaceutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics

CYPH 0.584

-7.2%

12:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john lilly who wrote ()	6/16/1998 1:35:00 PM
From: Axxel	Read Replies (1) of 428

CYPH news from Bloomberg 1PM...partial only: CYPH & Bristol Meyers Squibb have signed a license and research agreement related to production of paclitaxel, the active ingredient in BMS's largest selling cancer product, TAXOL (R). Terms of the announcement were not announced but include fees, milestone payments, research support and royalties on any eventual product sales. More later... From Bloomberg FYI

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next